Phase 2 Study of Adjuvant Radiotherapy Following Narrow‐Margin Hepatectomy in Patients With HCC-Reference-Cited by-同舟云学术

Phase 2 Study of Adjuvant Radiotherapy Following Narrow‐Margin Hepatectomy in Patients With HCC

Published:2021-09-16 Issue:5 Volume:74 Page:2595-2604
ISSN:0270-9139
Container-title:Hepatology
language:en
Short-container-title:Hepatology

Author:

Chen Bo¹,Wu Jian‐Xiong²,Cheng Shu‐Hui¹,Wang Li‐Ming²^ORCID,Rong Wei‐Qi²,Wu Fan²,Wang Shu‐Lian¹,Jin Jing¹,Liu Yue‐Ping¹,Song Yong‐Wen¹,Ren Hua¹,Fang Hui¹,Tang Yuan¹,Li Ning¹,Li Ye‐Xiong¹^ORCID,Wang Wei‐Hu¹³

Affiliation:

1. State Key Laboratory of Molecular Oncology Department of Radiation Oncology National Cancer Center/National Clinical Research Center for Cancer/Cancer HospitalChinese Academy of Medical Sciences, and Peking Union Medical College Beijing P. R. China

2. Department of Hepatobiliary Surgery National Cancer Center/National Clinical Research Center for Cancer/Cancer HospitalChinese Academy of Medical Sciences, and Peking Union Medical College Beijing P. R. China

3. Key Laboratory of Carcinogenesis and Translational Research Department of Radiation Oncology Peking University Cancer Hospital & Institute Beijing P. R. China

Publisher

Wiley

Subject

Hepatology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/hep.31993

Reference40 articles.

1. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries

2. Cancer statistics in China, 2015

3. Neoadjuvant and adjuvant therapy for resectable hepatocellular carcinoma: review of the randomised clinical trials

4. Resection and Liver Transplantation for Hepatocellular Carcinoma

5. Risk factors contributing to early and late phase intrahepatic recurrence of hepatocellular carcinoma after hepatectomy

Cited by 59 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. MRI-based prediction of the need for wide resection margins in patients with single hepatocellular carcinoma;European Radiology;2024-09-05

2. A novel risk scoring system predicts overall survival of hepatocellular carcinoma using cox proportional hazards machine learning method;Computers in Biology and Medicine;2024-08

3. The cumulative antitumor effects of regorafenib and radiotherapy in hepatocellular carcinoma;Molecular Carcinogenesis;2024-06-05

4. Stereotactic body radiation therapy in patients with centrally located hepatocellular carcinoma: A retrospective, single-arm, multi-center study;Clinical and Translational Radiation Oncology;2024-05

5. Adjuvant Therapy for Hepatocellular Carcinoma After Curative Treatment: Several Unanswered Questions;Journal of Clinical and Translational Hepatology;2024-04-24